These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2018248)

  • 1. The role of platelet-activating factor in asthma.
    Smith LJ
    Am Rev Respir Dis; 1991 May; 143(5 Pt 2):S100-2. PubMed ID: 2018248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The potential role and mechanism of leukotriene and platelet-activating factor in allergic disease].
    Yoshida K; Suko M
    Nihon Rinsho; 1993 Mar; 51(3):631-7. PubMed ID: 8492436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipid mediators in asthma (current views and perspectives).
    König W; Schönfeld W; Knöller J; Köller M
    Allergol Immunopathol (Madr); 1988; 16(5):289-98. PubMed ID: 3147587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet activating factor (PAF)-induced late asthmatic response in sensitized but not in non-sensitized guinea pigs].
    Arima M; Yukawa T; Terashi Y; Sagara H; Makino S
    Arerugi; 1992 May; 41(5):607-14. PubMed ID: 1520069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO
    Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PAF receptor antagonist in asthma therapy].
    Sagara H; Makino S; Fukuda T
    Nihon Rinsho; 1996 Nov; 54(11):3056-61. PubMed ID: 8950954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor (PAF) and PAF antagonists in asthma.
    Hosford D; Mencia-Huerta JM; Braquet P
    Crit Rev Ther Drug Carrier Syst; 1990; 7(3):261-73. PubMed ID: 2073689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of platelet activating factor-induced bronchoconstriction in humans.
    Smith LJ; Rubin AH; Patterson R
    Am Rev Respir Dis; 1988 May; 137(5):1015-9. PubMed ID: 3195800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of platelet activating factor and its antagonists in bronchial asthma].
    Massion PB; Frans A
    Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of inhaled aerosol of platelet activating factor on pulmonary function and airway responsiveness in normal subjects].
    Li Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):222-4, 255. PubMed ID: 1307517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.
    Kaye MG; Smith LJ
    Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):993-7. PubMed ID: 2183659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB
    Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eicosanoids and platelet-activating factor in allergic respiratory diseases.
    Henderson WR
    Am Rev Respir Dis; 1991 May; 143(5 Pt 2):S86-90. PubMed ID: 1902069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between PAF, platelets and eosinophils in bronchial asthma.
    Page CP; Coyle AJ
    Eur Respir J Suppl; 1989 Jun; 6():483s-487s. PubMed ID: 2679601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor.
    Christie PE; Henderson WR
    Clin Allergy Immunol; 2002; 16():233-54. PubMed ID: 11577541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of platelet-activating factor and its effect on the lung].
    Maki N; Kanda Y; Suzuki T; Miyauchi K; Wada Y; Johnston JM
    Rinsho Byori; 1993 Feb; 41(2):160-9. PubMed ID: 8361018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses.
    Evans DJ; Barnes PJ; Cluzel M; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Jul; 156(1):11-6. PubMed ID: 9230719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma.
    Landgraf RG; Nossi DF; Sirois P; Jancar S
    Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):163-72. PubMed ID: 17923399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bronchoconstrictor properties of platelet-activating factor in humans.
    Rubin AH; Smith LJ; Patterson R
    Am Rev Respir Dis; 1987 Nov; 136(5):1145-51. PubMed ID: 3314611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity.
    Page CP
    Int J Tissue React; 1987; 9(1):27-32. PubMed ID: 3298115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.